General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Milne HC et al. – This is the first angina drug approved by the FDA in over a decade. The unique thing about this drug is that it falls into a new class of therapies in that it works at the level of cellular metabolism in decreasing demand on the cardiac tissue. There are many factors to consider when prescribing this medication including past studies, dosing, and education. There is also evidence that this drug may also benefit diabetic patients with glycemic control.

Related Articles

Heart Study Shows Many Suffer Poor Quality Of Life
ScienceDaily, 10/13/09    Relevance Score: 64%

Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study
Arthritis & Rheumatism, 11/05/09    Relevance Score: 62%

T-Cell Recognition of Prostatic Peptides in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
The Journal of Urology, 10/14/09    Relevance Score: 47%

Chronic pain alters the structure of the brain
Schmerz, 10/20/09    Relevance Score: 45%

Chronic pain-related changes in endogenous opioid analgesia: A case report
Pain, 10/16/09    Relevance Score: 45%

Today in General Medicine...keeping you current

The relationship between primary health care organization and quality of diabetes care
The European Journal of General Practice, 12/17/09

Nurses 'must' control of the nutritional needs of stroke patients
British Journal of Nursing, 12/17/09

Somatoform disorders with pain as the predominant symptom
Schmerz, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address